15 series
Export
<<<Page of 1 >>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterExpression profiling by high throughput sequencing Remove filterTiphaine Christiane Martin
GSE198432
An epigenetic gene signature underlies phenotype switching in early stage melanomas.
 300 Tiphaine Christiane Martin May 08, 2024
GSE148379
Cooperation between distinct cancer drivers dictates inter-tumor heterogeneity in hepatocellular carcinoma
  • Expression profiling by high throughput sequencing
60 Tiphaine Christiane Martin Dec 16, 2020
GSE161180
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas
  • Expression profiling by high throughput sequencing
46 Tiphaine Christiane Martin Oct 30, 2023
GSE198425
Next Generation Sequencing of Primary Melanocytes, Epgn1, and Epgn3 Melanoma Cell lines [RNA-seq]
  • Expression profiling by high throughput sequencing
24 Tiphaine Christiane Martin May 08, 2024
GSE229576
Effect of vehicle or drug treatment on gene expression in p53-null and p53Y220C stable cell lines
  • Expression profiling by high throughput sequencing
16 Tiphaine Christiane Martin Sep 11, 2024
GSE155386
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [I]
  • Expression profiling by high throughput sequencing
12 Tiphaine Christiane Martin Oct 30, 2023
GSE155394
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [transfection]
  • Expression profiling by high throughput sequencing
12 Tiphaine Christiane Martin Oct 30, 2023
GSE218359
CD34+ HSPC CITE-seq for day 0 and Day 1 and Day 4 under VPA
  • Expression profiling by high throughput sequencing
10 Tiphaine Christiane Martin Apr 11, 2023
GSE161177
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [YUMMER1.7]
  • Expression profiling by high throughput sequencing
9 Tiphaine Christiane Martin Oct 30, 2023
GSE161178
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [YUMM 2.1]
  • Expression profiling by high throughput sequencing
9 Tiphaine Christiane Martin Oct 30, 2023
GSE277017
Effect of vehicle or drug treatment on gene expression in BxPC3 cell line
  • Expression profiling by high throughput sequencing
9 Tiphaine Christiane Martin Sep 26, 2024
GSE155180
Mitochondrial activity linked to CD34+CD90+EPCR+ phenotype determines the functional fitness of ex vivo expanded HSCs
  • Expression profiling by high throughput sequencing
6 Tiphaine Christiane Martin Nov 20, 2020
GSE198426
An epigenetic gene signature underlies phenotype switching in early stage melanomas [SKMel147]
  • Expression profiling by high throughput sequencing
6 Tiphaine Christiane Martin May 08, 2024
GSE198427
An epigenetic gene signature underlies phenotype switching in early stage melanomas [YUCHIME]
  • Expression profiling by high throughput sequencing
6 Tiphaine Christiane Martin May 08, 2024
GSE186382
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [single cell CD45+ YUMM 2.1]
  • Expression profiling by high throughput sequencing
4 Tiphaine Christiane Martin Oct 30, 2023